How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

1,049 results for

Fetal Heart Tracing

Latest & greatest

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

181. Guidelines For Professional Ultrasound Practice

do not and cannot cover all elements of an ultrasound examination and, in addition, ultrasound practitioners are advised to access standard texts, documents and research in order to fully inform local departmental protocols and procedures. There are no guidelines included for obstetric ultrasound in this edition. Practitioners are referred to publications from the national fetal anomaly screening programmes, the Royal College of Obstetricians and Gynaecologists (especially their Greentop (...) Guidelines), the Fetal Medicine Foundation, Association of Early Pregnancy Units, British Society of Gynaecological Imaging and the International Society of Ultrasound in Obstetrics and Gynaecology. The term patient has been used throughout the document in preference to other terms such as client or service user. Several professional titles are used by those who practice ultrasound and this can lead to considerable confusion. The term ultrasound practitioner is used throughout this document when

2018 British Medical Ultrasound Society

183. Risk factors for breast cancer: A review of the evidence 2018

133 4.8.2 Cardiac glycosides 134 4.8.3 HPV 136 4.8.4 Hysterectomy 137 4.8.5 Pregnancy termination 139 4.8.6 Previous cancer other than breast cancer 140 4.8.7 Silicone breast implants 143 4.8.8 Stress 145 4.8.9 Trauma to the breast 147 4.8.10 Type 2 diabetes 148 4.9 Chemical exposures 150 4.9.1 Bisphenol A (BPA) 150 4.9.2 DDT exposure 151 4.9.3 Deodorant/antiperspirant 152 4.9.4 Dioxin 153 4.9.5 Ethylene oxide 155 4.9.6 Land contamination 156 4.9.7 Outdoor air pollution 158 4.9.8 Parabens 160 (...) and risk of breast cancer 393 Table D.53 Diet—processed meat and risk of breast cancer 395 Table D.54 Diet—red meat and risk of breast cancer 398 Table D.55 Environmental tobacco smoke and risk of breast cancer 401 Table D.56 Tobacco smoking and risk of breast cancer 405 Table D.57 Physical activity and risk of breast cancer 409 Table D.58 Shift work disrupting circadian rhythm and risk of breast cancer 415 Table D.59 Aspirin and risk of breast cancer 420 Table D.60 Cardiac glycosides and risk

2018 Cancer Australia

184. Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada

. Prebtani MD, FRCPC, Vincent Woo MD, FRCPC S190 Management of Acute Coronary Syndromes Jean-Claude Tardif MD, FRCPC, FACC, FCAHS, Phillipe L. L'Allier MD, David H. Fitchett MD, FRCPCCONTENTS (continued): April 2018 Volume 42 Supplement 1 S196 Treatment of Diabetes in People With Heart Failure Kim A. Connelly MBBS, PhD, FCCS, Richard E. Gilbert MBBS, PhD, Peter Liu MD, FRCPC, FACC S201 Chronic Kidney Disease in Diabetes Philip McFarlane MD, PhD, FRCPC, David Cherney MD, PhD, FRCPC, Richard E. Gilbert (...) , ON Olivier F. Bertrand MD PhD Associate Professor of Medicine Quebec Heart–Lung Institute, Laval University, QC Acknowledgment / Can J Diabetes 42 (2018) A6–A16 Kim Connelly MBBS PhD Associate Professor Division of Cardiology, Department of Medicine, University of Toronto, Director, Krembil Stem Cell Facility, President, Canadian Society for Cardiac MRI, St. Michael’s Hospital, Toronto ON Michael Coons CPsych CBSM Clinical Health Psychologist Medical Bariatrics and Diabetes, St. Joseph’s Healthcare

2018 Diabetes Canada

185. Management Of Haemophilia

& Trauma Surgeon Gleneagles Hospital, Kuala Lumpur Associate Professor Dr. Azlan Husin Consultant Physician & Clinical Haematologist Hospital Universiti Sains Malaysia, Kelantan Dr. Carol Lim Kar Koong Head of Department & Consultant Obstetrician & Gynaecologist (Maternal Fetal Medicine) Hospital Sultan Ahmad Shah, Pahang Ms. Haironi Ismail Physiotherapist Hospital Putrajaya, Putrajaya Ms. Halimah Hashim Physiotherapist Hospital Raja Perempuan Zainab II, Kelantan Dr. Jalil Ishak Family Medicine (...) ): 20 mg/kg stat, then15 mg/kg every 4 - 6-hourly Max: 60 mg/kg (up to 90 mg/kg for 48 hours) Selective Cox-2 Inhibitors Celecoxib Adults (oral): 100 - 400 mg, 12 - 24-hourly Max: 800 mg/day Not recommended in severe renal and/or hepatic impairment Initiate therapy at lowest recommended dose in elderly Ischaemic heart disease Cerebrovascular disease Contraindicated in hypersensitivity to sulfonamides Associated with a lower risk of serious upper gastrointestinal side effects compared to NSAIDs

2018 Ministry of Health, Malaysia

186. Antithrombotic Therapy for Atrial Fibrillation: CHEST Guideline and Expert Panel Report

. For patients with AF and stable coronary artery disease (eg, no acute coronary syndrome within the previous year) and who choose oral anticoagulation, we suggest OAC with either an NOAC or adjusted- dose VKA therapy alone (target international normalized ratio [INR] range, 2.0-3.0) rather than the combination of OAC and aspirin (Weak recommendation, low quality evidence). 32. In patients with AF in whom catheter ablation of AF or implantation of cardiac electronic implantable devices is planned, we suggest (...) and signpost the patient to appropriate educational resources. Introduction Atrial ?brillation (AF) is the most common sustained cardiac arrhythmia, with an increasing prevalence and incidencewithage.Inadultsaged>40years,thereisa1 in 4 lifetime risk of developing AF, with incident AF commonly related to various associated cardiovascular and noncardiovascular risk factors. AF without associated valvular heart disease (so-called “nonvalvular AF”) is associated with a ?vefold increase in stroke risk

2018 American College of Chest Physicians

188. Pediatric Gastroesophageal Reflux Clinical Practice Guidelines: Joint Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutritio

)/factitious disorder by proxy (FDP) Hereditary fructose intolerance Child neglect or abuse Urea cycle defects Self-induced vomiting Amino and organic acidemias Cyclic vomiting syndrome Fatty acid oxidation disorders Rumination syndrome Metabolic acidosis Congenital adrenal hyperplasia/adrenal crisis Toxic Renal Lead poisoning Obstructive uropathy Other toxins Renal insuf?ciency Cardiac Heart failure Vascular ring Autonomic dysfunction ESPGHAN ¼ European Society for Pediatric Gastroenterology, Hepatology (...) indications for the performance of pH-MII in the evaluation of GERD. 1. Differentiate patients with NERD, hypersensitive esopha- gus and functional heartburn in patients with normal endoscopy. The recently published Rome IV criteria for esophageal disorders included new classi?cations for adults with typical GERD symptoms including chest pain and heart burn. In patients with persistent typical symptoms despite acid suppression, pH-MII can clarify the diagnosis of NERD (pathologic re?ux regardless

2018 North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition

189. The use of viscoelastic haemostatic assays in the management of major bleeding Full Text available with Trip Pro

management has been reported to improve overall clinical outcomes after cardiac surgery (Weber et al , ; Sartorius et al , ; Pearse et al , ; Trevisan et al , ), and result in less bleeding and lower need for re‐exploration after coronary artery bypass grafting (CABG) (Speiss et al , ). Duration of hospitalisation was also reduced (Ichikawa et al , ). Conversely, a recent systematic review of 15 randomised trials involving 8737 patients found no significant difference in mortality, reoperation (...) Online Library Terms and Conditions of Use. Shareable Link Use the link below to share a full-text version of this article with your friends and colleagues. Copy URL Share a link ) and 10% of cardiac surgery patients (Serraino & Murphy, ). Blood loss is one of the main causes of morbidity following liver transplantation (Gurusamy et al , ) and is one of the most common causes of death worldwide in women at the time of delivery (Say et al , ). Diagnosis of major bleeding is difficult and is often made

2018 British Committee for Standards in Haematology

190. CRACKCast E180 – Labor & Delivery

, the strength of the contractions correlates poorly with the tracing. The tracings are position and placement sensitive. Fetal heart rate tracings have several components that can be assessed—baseline heart rate, variability, accelerations, decelerations, and diagnostic patterns. Ultrasonography the gestational age, biophysical profile, amniotic fluid index, and a survey of fetal and placental anatomy may be obtained. What are the indications for foetal monitoring during labour? -> Labouring woman 4 (...) information, limited assistance with intrapartum decision making External electronic fetal monitoring uses tracings of the fetal heart rate and uterine activity. helps confirm true labor and may help diagnose fetal distress. In combination with clinical data, this can portend fetal distress due to hypoxia and provide a window for intervention. Uterine activity is measured transabdominally by a pressure transducer, creating a recording of the contraction frequency. Because the measurements are indirect

2018 CandiEM

192. Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy

of VTE, mechanical heart valves, and atrial fibrillation. In addition, patients with bare metal or drug-eluting coronary stents require antiplatelet therapy with aspirin and thienopyridine derivatives (eg, clopidogrel) for varying durations. These patients may present for elective or urgent surgical procedures. Perioperative management involves balancing the risks of surgical bleeding and thromboembolism. Minor procedures may not require interruption of antithrombotic or antiplatelet therapy. However (...) . In other patients, bridging anticoagulation with UFH or LMWH is required until the time of surgery (and reinitiated in the immediate postoperative period). It may also be necessary to postpone elective surgeries in patients where a suitable “bridge” has not been identified and antithrombotic therapy is critical; premature discontinuation of dual antiplatelet therapy in patients with coronary stents has been associated with stent thrombosis, myocardial infarction, and death ( and ). Evidence-based

2018 American Society of Regional Anesthesia and Pain Medicine

193. WHO recommendations: intrapartum care for a positive childbirth experience

for assessment of fetal well-being in healthy pregnant women undergoing spontaneous labour. Not recommended Intermittent fetal heart rate auscultation during labour 18. Intermittent auscultation of the fetal heart rate with either a Doppler ultrasound device or Pinard fetal stethoscope is recommended for healthy pregnant women in labour. Recommended Epidural analgesia for pain relief 19. Epidural analgesia is recommended for healthy pregnant women requesting pain relief during labour, depending on a woman’s (...) ), a cosponsored programme executed by the WHO. The views of the funding bodies have not influenced the content of this guideline. Editing: Green Ink, United Kingdom.vii ACRONYMS AND ABBREVIATIONS Acronyms and abbreviations ABO adverse birth outcome aOR adjusted odds ratio CERQual Confidence in the Evidence from Reviews of Qualitative research CI confidence interval cRCT cluster randomized controlled trial CTG cardiotocography DOI declaration of interest EB evidence base EtD evidence-to-decision FHR fetal

2018 World Health Organisation Guidelines

194. Perioperative Ketorolac-lidocaine in the Patients With Valvular Heart Diseases During Cesarean Delivery

, preload, coronary perfusion, and cardiac output. Many women still prefer general anesthesia rather than regional techniques at the author's country. The pharmacological modifications of the sympathetic response to tracheal intubation and surgical stimulation using opioids have adverse effects on the neonatal outcome after cesarean delivery. The authors have demonstrated in their previous studies the safety of both perioperative infusion of both of ketorolac and lidocaine in the attenuation (...) Perioperative Ketorolac-lidocaine in the Patients With Valvular Heart Diseases During Cesarean Delivery Perioperative Ketorolac-lidocaine in the Patients With Valvular Heart Diseases During Cesarean Delivery - Full Text View - Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100

2012 Clinical Trials

195. Maternal heart rate patterns in the 1(st) and 2(nd) stages of labor. (Abstract)

: +35±13bpm; 88±14 to 123±17bpm; p<0.001). MHR was persistently >100bpm in three women (17%) in the first stage, and in four women (27%) in the second stage. Peak MHR >140bpm occurred during pushing in 20%. Conclusion. Decreases in MHR during contractions in the first stage of labor can mimic fetal heart rate (FHR) accelerations as well as early type decelerations. Thus, first stage tracings with a low baseline and early type decelerations may be maternal in origin and FHR should be independently (...) Maternal heart rate patterns in the 1(st) and 2(nd) stages of labor. Objective. To analyze typical maternal heart rate (MHR) patterns in the first and second stages of labor. Design. Observational study. Setting. Tertiary care community hospital. Population. Normal term parturients with epidural anesthesia. Methods. Confirmed MHR and uterine activity were simultaneously recorded. The average MHR was analyzed 10 seconds before, as well as at the peak of, each contraction and/or pushing effort

2012 Acta Obstetricia et Gynecologica Scandinavica

196. Preterm labour and birth

blood cell count and measurement of fetal heart rate using cardiotocography) to diagnose intrauterine infection in women with P-PROM. 1.5.2 Do not use any one of the following in isolation to confirm or exclude intrauterine infection in women with P-PROM: a single test of C-reactive protein white blood cell count measurement of fetal heart rate using cardiotocography. 1.5.3 If the results of the clinical assessment or any of the tests are not consistent with each other, continue to observe the woman (...) reducing the dose of magnesium sulfate. 1.11 Fetal monitoring Monitoring options: cardiotocogr Monitoring options: cardiotocograph aphy and intermittent auscultation y and intermittent auscultation 1.11.1 Discuss with women in suspected, diagnosed or established preterm labour (and their family members or carers as appropriate): the purpose of fetal monitoring and what it involves the clinical decisions it informs at different gestational ages if appropriate, the option not to monitor the fetal heart

2015 National Institute for Health and Clinical Excellence - Clinical Guidelines

198. The impact of particulate matter 2.5 on the risk of preeclampsia: an updated systematic review and meta-analysis Full Text available with Trip Pro

quality to maintain the health of pregnant women. Introduction Preeclampsia is the most common pregnancy-related complication with no effective cure, which presents as a syndrome of elevated maternal blood pressure and/or proteinuria in pregnant women after 20 weeks of gestation (Shah ); it affects 3–7% of pregnancies in the world. Moreover, it is one of the major causes of increased maternal and fetal morbidity and mortality (Lyall et al. ; Steegers et al. ). The pathogenesis of preeclampsia (...) , period, exposure assessment method, exposure stage, and covariate adjustment, were extracted and are summarized in Table . Supplementary materials and relevant clues were traced when the main manuscripts lacked necessary data. If necessary, the authors of the included original studies were contacted for additional details. Table 1 Main details of original studies included in this meta-analysis Quality assessment Two investigators (Hongbiao Yu and Yangxue Yin) used the combined criteria performed

2020 Environmental Science and Pollution Research

199. Outcomes of endotracheal suctioning in non-vigorous neonates born through meconium-stained amniotic fluid: a systematic review and meta-analysis Full Text available with Trip Pro

III fetal heart rate (absent baseline fetal heart rate tracing with recurrent late decelerations, or recurrent variable decelerations or bradycardia and sinusoidal pattern). Meconium consistency thin: watery-consistency fluid; moderate: opaque fluid without particles; and thick: pea-soup consistency or opaque fluid containing particulate material Respiratory problems: MAS: neonates with respiratory distress of unexplained origin on chest X-ray and symptoms owing to other diseases (radiographic (...) according to systematic classification, including resuscitation and neonatal outcomes ( ). View this table: Table 1 Summary of the four included randomised controlled trials (RCTs) View this table: Table 2 Maternal and neonatal characteristics View this table: Table 3 Outcomes by system Similar definitions used in most studies and some variables were defined, as below. Non-vigorous: heart rate <100 beats per minute (bpm), decreased muscle tone, not breathing/crying or gasping Fetal distress: category

2020 Archives of Disease in Childhood - Fetal and Neonatal Edition

200. Canadian guidelines for controlled pediatric donation after circulatory determination of death-summary report Full Text available with Trip Pro

in these cases. Regarding GPS 36, in the past, when DCD was more commonly referred to as “donation after cardiac death,” authors argued that determining death by irreversible loss of cardiac function precluded DCD cardiac transplantation ( , ). However, our guidelines specifically define death as permanent loss of circulation in the donor. Whether the heart remains unresuscitated in the donor or is removed and resuscitated in another patient does not alter donor outcome: body and brain circulation remains (...) in cardiac pDCD: a) Cardiac transplant programs should establish criteria for acceptance of heart donation, ex vivo cardiac protocols, and heart allocation in pDCD, b) Consideration should be given to initiate cardiac pDCD program as either research protocols with research ethics board oversight or through programs that oversee innovative therapies. | Justification. Although there is minimal published experience with cardiac pDCD ( ), recent innovative reports of adult cardiac DCD using ex vivo heart

2017 CPG Infobase

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>